M2Bio Sciences, Inc.

M2Bio Sciences, Inc.

Alternative Medicine

At the forefront of medicinal cannabis and mushrooms - Trading on the OTC: $MRES

About us

M2Bio Sciences, Inc. is a nutraceutical biotechnology company that researches, develops and commercialises a range of CBD-based products under the Dr. AnnaRx™, Medspresso™ and Liviana™ brands. In addition, its new wholly-owned division, is researching and developing indications for psilocybin new therapies that will help patients who suffer from mental illness, Alzheimer's and Parkinson's. Our vision is to improve people’s quality of life by unleashing the full potential of medicinal cannabis and mushrooms. Our mission is to advance botanical-based medicine to the forefront. From seed to shelf and spore to store, we are driven by a passion for medicine and science. We live by the values of: Quality. Excellence. Science. Traceability. Accountability. Humility. M2Bio is listed and traded on the Over The Counter Bulletin Board of NASDAQ under the trading symbol “$MRES”. The global market for legal cannabis is according to Euromonitor International anticipated to grow 1,283 percent in value of sales, in the next seven years, from US$12B to US$166B at a CAGR of 45.5 percent (2018-2025), subject to increased legalisation.

Website
https://m2bio.co
Industry
Alternative Medicine
Company size
11-50 employees
Headquarters
Cape Town
Type
Public Company
Founded
2018
Specialties
Cannabis, Cannabidiol, Medicine, Biotechnology, Psilocybin, Medicinal Mushrooms, Health , Neuroscience, and Alternative Medicine

Locations

Employees at M2Bio Sciences, Inc.

Updates

  • View organization page for M2Bio Sciences, Inc., graphic

    2,275 followers

    𝑪𝒐𝒇𝒇𝒆𝒆 & 𝒀𝒐𝒖𝒓 𝑯𝒆𝒂𝒓𝒕: 𝑨 𝑩𝒓𝒆𝒂𝒌𝒅𝒐𝒘𝒏 𝒐𝒇 𝒕𝒉𝒆 𝑼𝑲 𝑩𝒊𝒐𝒃𝒂𝒏𝒌 𝑺𝒕𝒖𝒅𝒚 ☕️🫀 Researchers analyzed data from over 449,000 UK Biobank participants to see how different coffee types affect heart health and mortality. 𝑻𝒉𝒆 𝑮𝒐𝒐𝒅 𝑵𝒆𝒘𝒔: All types of coffee (decaf, ground, and instant) were linked to a lower risk of heart disease and death compared to non-coffee drinkers. 𝑻𝒉𝒆 𝑺𝒘𝒆𝒆𝒕 𝑺𝒑𝒐𝒕: The study suggests a "sweet spot" for coffee consumption – around 2-3 cups per day for all types offered the most significant benefits. 𝑨 𝑹𝒉𝒚𝒕𝒉𝒎 & 𝑩𝒍𝒖𝒆𝒔 𝑵𝒐𝒕𝒆: Interestingly, ground and instant coffee (but not decaf) were associated with a lower risk of arrhythmias (irregular heartbeats) at moderate intake (1-5 cups/day). This warrants further investigation. Overall, this is promising! 𝑴𝒐𝒅𝒆𝒓𝒂𝒕𝒆 𝒄𝒐𝒇𝒇𝒆𝒆 𝒄𝒐𝒏𝒔𝒖𝒎𝒑𝒕𝒊𝒐𝒏 could be part of a heart-healthy lifestyle. 𝑯𝒐𝒘𝒆𝒗𝒆𝒓, 𝒓𝒆𝒎𝒆𝒎𝒃𝒆𝒓: 𝑪𝒐𝒓𝒓𝒆𝒍𝒂𝒕𝒊𝒐𝒏 ≠ 𝑪𝒂𝒖𝒔𝒂𝒕𝒊𝒐𝒏: This study can not establish direct causation. 𝑰𝒏𝒅𝒊𝒗𝒊𝒅𝒖𝒂𝒍 𝑵𝒆𝒆𝒅𝒔 𝑴𝒂𝒕𝒕𝒆𝒓: Some are more sensitive to caffeine and may experience anxiety or sleep issues. Listen to your body! 𝑸𝒖𝒂𝒍𝒊𝒕𝒚 𝑪𝒐𝒖𝒏𝒕𝒔: Sugary coffee drinks and excessive cream can negate potential benefits. Opt for black coffee or minimal additions. 𝑻𝒉𝒆 𝑻𝒂𝒌𝒆𝒂𝒘𝒂𝒚: Enjoy your coffee in moderation, but maintain a balanced diet and regular exercise for a truly healthy heart. Read the full study: https://lnkd.in/djSRB24r 𝑺𝒕𝒂𝒚 𝒄𝒖𝒓𝒊𝒐𝒖𝒔, 𝒔𝒕𝒂𝒚 𝒉𝒆𝒂𝒍𝒕𝒉𝒚! #coffee #hearthealth #ukbiobank #preventivemedicine

    The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality: long-term outcomes from the UK Biobank - PubMed

    The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality: long-term outcomes from the UK Biobank - PubMed

    pubmed.ncbi.nlm.nih.gov

  • View organization page for M2Bio Sciences, Inc., graphic

    2,275 followers

    Ⓑⓡⓞⓒⓒⓞⓛⓘ Power! Could it Revolutionize Stroke Treatment? Calling all broccoli lovers! This humble veggie might hold the key to a major breakthrough in stroke treatment. 𝙏𝙝𝙚 𝙋𝙧𝙤𝙗𝙡𝙚𝙢: Stroke is a leading cause of death worldwide, often caused by blood clots in the brain. Current clot-busting drugs like tissue plasminogen activator(tPA) come with a risk of bleeding in the brain, a potentially deadly side effect. 𝙀𝙣𝙩𝙚𝙧 𝘽𝙧𝙤𝙘𝙘𝙤𝙡𝙞'𝙨 𝙎𝙪𝙥𝙚𝙧𝙥𝙤𝙬𝙚𝙧: Researchers in Australia discovered that sulforaphane, a natural compound found in broccoli and other cruciferous veggies, might be a game-changer. Studies show sulforaphane can: Improve the effectiveness of tPA, potentially increasing its success rate to 60%. Reduce blood clot formation. Potentially slow down the onset of stroke. Unlike other blood thinners, sulforaphane appears to not increase the risk of bleeding. 𝙏𝙝𝙚 𝙁𝙪𝙩𝙪𝙧𝙚 𝙤𝙛 𝘽𝙧𝙤𝙘𝙘𝙤𝙡𝙞 𝙋𝙤𝙬𝙚𝙧: Human trials are next! Researchers aim to develop a new preventative and anti-clotting treatment using sulforaphane within 5 years. If successful, this could revolutionize stroke treatment, offering a safer and more effective option for patients. 𝙇𝙞𝙢𝙞𝙩𝙖𝙩𝙞𝙤𝙣𝙨: These are still early-stage findings. More research is needed to confirm the benefits in humans. 𝙏𝙝𝙚 𝙏𝙖𝙠𝙚𝙖𝙬𝙖𝙮: Eating fruits and veggies is good for overall health, and broccoli might offer additional benefits for stroke prevention. But don't ditch your doctor's advice just yet! Talk to them about stroke prevention strategies specific to you. Link to original study: https://lnkd.in/ezgbUmuk #stroke #strokeprevention #broccoli #sulforaphane #research

    Integrating Phenotypic and Chemoproteomic Approaches to Identify Covalent Targets of Dietary Electrophiles in Platelets

    Integrating Phenotypic and Chemoproteomic Approaches to Identify Covalent Targets of Dietary Electrophiles in Platelets

    pubs.acs.org

  • View organization page for M2Bio Sciences, Inc., graphic

    2,275 followers

    𝗖𝗮𝗻 Ⓜⓤⓢⓗⓡⓞⓞⓜⓢ 𝗕𝗲 𝘁𝗵𝗲 𝗡𝗲𝘄 𝗙𝗿𝗼𝗻𝘁𝗶𝗲𝗿 𝗳𝗼𝗿 ⓂⒺⓃⓉⒶⓁ 𝗛𝗲𝗮𝗹𝘁𝗵? This time, we're examining the world of mushrooms and their potential to revolutionize mental health treatment. 𝙏𝙝𝙚 𝙎𝙩𝙪𝙙𝙮: Researchers are exploring the power of natural mushroom compounds, specifically those containing psilocybin (the psychedelic stuff). 𝙒𝙝𝙮 𝙄𝙩 𝙈𝙖𝙩𝙩𝙚𝙧𝙨: Millions of people struggle with treatment-resistant psychiatric conditions like depression, OCD, and schizophrenia. Traditional medications often leave them hanging, highlighting the need for new approaches. 𝙒𝙝𝙖𝙩 𝙏𝙝𝙚𝙮 𝙁𝙤𝙪𝙣𝙙: The study suggests that mushroom extracts containing psilocybin might be more effective than pure, synthesized psilocybin. These extracts seem to have a stronger and longer-lasting impact on brain plasticity, which is key for learning and emotional regulation. Additionally, the chemical makeup of the extract appears to be different from synthesized psilocybin, potentially offering unique therapeutic benefits. 𝙇𝙞𝙢𝙞𝙩𝙖𝙩𝙞𝙤𝙣𝙨: This study was done in mice, so we can't jump to human results just yet. 𝙏𝙧𝙖𝙙𝙞𝙩𝙞𝙤𝙣𝙖𝙡 𝙫𝙨. 𝙉𝙖𝙩𝙪𝙧𝙖𝙡: 𝘼 𝙉𝙚𝙬 𝙋𝙖𝙧𝙖𝙙𝙞𝙜𝙢? Western medicine usually isolates active compounds for better control. Ancient practices, however, often used whole plants or mushrooms (think: eating the entire mushroom!). This study suggests that these natural extracts might hold advantages due to the "entourage effect" – the idea that various compounds work together synergistically. 𝙏𝙝𝙚 𝙁𝙪𝙩𝙪𝙧𝙚 𝙤𝙛 𝙋𝙨𝙮𝙘𝙝𝙚𝙙𝙚𝙡𝙞𝙘 𝙈𝙚𝙙𝙞𝙘𝙞𝙣𝙚: While challenges like maintaining consistent compound profiles in extracts exist, controlled mushroom cultivation offers a solution. This research paves the way for incorporating natural mushroom extracts into Western medicine, potentially offering a new class of innovative and personalized treatments. Remember, this is early-stage research, but it's exciting! Link to study:https://lnkd.in/eBPDxgsu Link to original article: https://lnkd.in/dFW8xy5p #mentalhealth #psychedelictherapy #mushrooms #research #futureofmedicine

    Exploring the therapeutic potential of natural mushroom compounds to address psychiatric disorders

    Exploring the therapeutic potential of natural mushroom compounds to address psychiatric disorders

    medicalxpress.com

Similar pages

Browse jobs

Funding

M2Bio Sciences, Inc. 1 total round

Last Round

Post IPO equity

US$ 450.0K

See more info on crunchbase